...
首页> 外文期刊>Biochemical and Biophysical Research Communications >GCN2 suppression attenuates cerebral ischemia in mice by reducing apoptosis and endoplasmic reticulum (ER) stress through the blockage of FoxO3a-regulated ROS production
【24h】

GCN2 suppression attenuates cerebral ischemia in mice by reducing apoptosis and endoplasmic reticulum (ER) stress through the blockage of FoxO3a-regulated ROS production

机译:通过减少凋亡和内质网(ER)胁迫通过堵塞FOXO3A监管的ROS生产来抑制小鼠中的脑缺血

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Ischemic stroke is one of the leading causes of morbidity and mortality among human worldwide. Unfortunately, cerebral I/R still lacks effective therapeutic targets and strategies. In the study, we found that general control nonderepressible 2 (GCN2) expression was increased following ischemia in the ischemic penumbra in vivo and in vitro. GCN2 suppression using its significant inhibitor, GCN2iB, exhibited a protective role in cerebral I/R injury in mice, as evidenced by the improved neurological deficits and function. GCN2 inhibition with either GCN2iB or genetic knockdown led to significant reduction of proapoptotic protein expression, endoplasmic reticulum stress (ERS)-related protein and oxidative stress both in I/R-induced cerebral injury and oxygen-glucose deprivation and reoxygenation (OGD/R) stimulation in N2a cells. OGD/R-triggered apoptosis and ERS were significantly depended on oxidative stress in vitro. In addition, Forkhead box O 3a (FoxO3a), involved in the reactive oxygen species (ROS) production, was increased during OGD/R stimulation-regulated apoptosis and ERS, which could be abrogated by GCN2 suppression. Consistently, FoxO3a-regulated generation of ROS was markedly ameliorated upon GCN2 suppression with GCN2iB. Thereby, our findings indicated that GCN2 suppression alleviated apoptosis and ERS in cerebral ischemia through reducing FoxO3a-dependent ROS production, illustrating that GCN2 could be a promising target for the therapeutic interventions in cerebral ischemic stroke. (C) 2019 Published by Elsevier Inc.
机译:缺血性卒中是人类世界各地发病率和死亡率的主要原因之一。不幸的是,脑I / R仍然缺乏有效的治疗目标和策略。在该研究中,我们发现,在体内和体外缺血血症中的缺血后,将一般对照非胶版2(GCN2)表达增加。 GCN2使用其显着抑制剂GCN2抑制GCN2在小鼠中表现出在脑I / R损伤中的保护作用,如改善的神经效率和功能所证明。 GCN2抑制GCN2或遗传敲低导致促液蛋白表达,内质网应激(ERS) - 诱导的脑损伤和氧葡萄糖剥夺和氧化术(OGD / R)的抑制蛋白表达在N2A细胞中刺激。 OGD / R触发的细胞凋亡和分解在体外显着取决于氧化胁迫。此外,在OGD / R刺激调节的细胞凋亡和E10S期间,涉及反应性氧物质(ROS)产生的FORKHEAD盒O 3A(FOXO3A)增加,其可以通过GCN2抑制消除。始终如一地,在GCN2抑制与GCN2BIB抑制时,FOXO3A调节的ROS显着改善。因此,我们的研究结果表明,通过还原FoxO3A依赖性的ROS生产,GCN2抑制通过减少脑缺血中的凋亡和ERS,说明GCN2可能是脑缺血性卒中中治疗干预的有希望的靶标。 (c)2019由elsevier公司出版

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号